Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00879086

Completed

A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer

Breast Cancer
NCT03612596

Completed

Narrative Visualization for Breast Cancer Survivors' Physical Activity

Breast Cancer
NCT03383835

Active, not recruiting

Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer

Breast Cancer
NCT02586025

Completed

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel (PEONY)

Breast Cancer
NCT00323908

Completed

Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer

Breast Cancer
NCT05246735

Completed

Frequency Domain Optical Imaging

Breast Cancer
NCT03084939

Completed

Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer

Breast Cancer
NCT05839288

Completed

Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic Breast Cancer Patients

Breast Cancer
NCT00337649

Completed

A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

Breast Cancer
NCT04396626

Terminated

HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes

Breast Cancer
NCT04836520

Completed

SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.

Breast Cancer
NCT05118568

Completed

Assessment of Lumpectomy Margins With the Histolog Scanner in Comparison With Intraoperative Imaging Techniques (Polarhis)

Breast Cancer
NCT04303741

Active, not recruiting

A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC

Breast Cancer
NCT05594082

Active, not recruiting

Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer

Breast Cancer
NCT00258960

Completed

Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

Breast Cancer
NCT00432172

Completed

Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients

Breast Cancer
NCT00841828

Completed

Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients

Breast Cancer
NCT00251433

Terminated

GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer

Neoplasms, Breast
NCT03121989

Withdrawn

Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy (LABC)

Breast Cancer
NCT01565499

Completed

Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer

Breast Cancer
NCT03375827

Completed

Feasibility of an Individualized Goals of Care Discussion Guide for Advanced Breast Cancer

Breast Cancer
NCT05228210

Terminated

Breast Cancer Self-Efficacy Scale for Partners (BCSES-P)

Breast Cancer
NCT03772353

Active, not recruiting

Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer (PLEASURABLE)

Breast Cancer
NCT00129922

Completed

Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

Breast Cancer
NCT00128843

Completed

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

Breast Cancer
NCT04307407

Completed

Exercise in Breast Cancer Survivors

Breast Cancer
NCT04638712

Completed

Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients (PROTECT-03)

Breast Cancer
NCT01446016

Completed

Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT) (CAT)

Breast Cancer | Breast Neoplasms
NCT03433313

Completed

Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer

Breast Cancer
NCT04679207

Completed

A Pilot Study of Ultrasound-guided Vacuum-assisted Excision of Breast Cancers (PICASSO)

Breast Cancer
NCT02067416

Withdrawn

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

Breast Cancer
NCT00028340

Completed

High-Risk Breast Duct Epithelium

Breast Cancer
NCT02261389

Active, not recruiting

Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET

Breast Cancer
NCT02669576

Completed

Mind-Body Medicine Day Care Clinic in Breast Cancer Patients Undergoing Endocrine Therapy (ENDOTK)

Breast Cancer
NCT00887380

Active, not recruiting

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) (STARS)

Breast Cancer
NCT04874935

Completed

The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer

Breast Cancer
NCT05158452

Completed

Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer

Breast Carcinoma
NCT01795586

Completed

A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients

Breast Cancer
NCT04676516

Completed

A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer (OTT-19-06)

Breast Cancer
NCT01057069

Active, not recruiting

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer (neo-TN)

Breast Cancer
NCT04818125

Completed

Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer. (CARMMYC)

Breast Cancer
NCT02113553

Terminated

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Breast Cancer
NCT03684408

Completed

Radiofrequency Chip for Localization of Non-Palpable Breast Lesions

Breast Tumor
NCT05501158

Active, not recruiting

CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population

Breast Cancer
NCT02679755

Completed

Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer

Breast Cancer
NCT04261218

Completed

Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer

Breast Cancer
NCT05275361

Completed

Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women

Breast Cancer
NCT05089903

Completed

Breast Cancer Outreach Among Primary Care Patients

Breast Cancer
NCT00533663

Completed

Healing Touch During Chemotherapy Infusions for Women With Breast Cancer

Breast Cancer
NCT01966471

Completed

A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations